News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gold Standard Diagnostics Launches Axis-Shield PLC’s New and Improved Anti-CCP2 Assay for Early and Accurate Diagnosis of Rheumatoid Arthritis


12/6/2011 7:30:17 AM

DAVIS, Calif.--(BUSINESS WIRE)--Gold Standard Diagnostics, Corp. (GSD) a leading supplier of products and services to the medical diagnostic industry today announced the launch of Axis-Shield’s new and improved Anti-CCP2 assay in the U.S. Market. Axis-Shield’s FDA cleared Anti-CCP2 assay is a new, highly sensitive and specific second generation peptide based test that enables early and accurate diagnosis of rheumatoid arthritis.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES